Literature DB >> 6540106

Effect of 2,4-diamino-6-(2,5-dichlorophenyl)-s-triazine maleate (MN-1695) on gastric ulcers and gastric secretion in experimental animals.

F Ueda, S Aratani, K Mimura, K Kimura, A Nomura, H Enomoto.   

Abstract

The effect of 2,4-diamino-6-(2,5-dichlorophenyl)-s-triazine maleate (MN-1695) on various experimental gastric ulcers and gastric secretion in experimental animals was compared with that of cimetidine and cetraxate. MN-1695 significantly inhibited the formation of Shay, stress-induced, indomethacin-induced, and histamine-induced ulcers and significantly accelerated the healing of acetic acid-induced gastric ulcers. MN-1695 was much more effective in suppressing stress- and acetic acid-induced ulcers than indomethacin-induced, histamine-induced or Shay ulcers. Cimetidine was effective in preventing stress- and acetic acid-induced ulcers but had no significant effect on Shay, indomethacin-induced and histamine-induced ulcers. Cetraxate was effective in preventing only stress-induced ulcers and had almost no effect on other experimental ulcers. MN-1695 inhibited secretion of gastric juice, acid and pepsin in Shay rats, but had no influence on basal and secretagogue-stimulated acid secretion in the perfused stomach of urethanized rats. These findings suggest that MN-1695 is a new type of anti-ulcer agent.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6540106

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  4 in total

1.  Protective effect of Irsogladine on monochloramine induced gastric mucosal lesions in rats:a comparative study with rebamipide.

Authors:  H Yamamoto; M Umeda; H Mizoguchi; S Kato; K Takeuchi
Journal:  World J Gastroenterol       Date:  1999-12       Impact factor: 5.742

2.  Effects of irsoglandine maleate in an experimentally-induced acute hepatic failure model using mice.

Authors:  Y Mizoguchi; N Kawada; Y Ichikawa; K Kobayashi; S Morisawa
Journal:  Gastroenterol Jpn       Date:  1991-04

3.  Complete disappearance of metastatic abdominal tumors from gastric cancer after treatment with irsogladine maleate.

Authors:  T Hosokawa; Y Otani; K Ogawa; T Kajiwara
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

4.  Irsogladine maleate suppresses indomethacin-induced elevation of proinflammatory cytokines and gastric injury in rats.

Authors:  Xin Zhang; Koyuki Tajima; Kiyoto Kageyama; Takashi Kyoi
Journal:  World J Gastroenterol       Date:  2008-08-14       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.